We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Intermediate Capital Group Plc | LSE:ICG | London | Ordinary Share | GB00BYT1DJ19 | ORD 26 1/4P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 50.00 | 2.42% | 2,120.00 | 477,898 | 16:35:01 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 2,114.00 | 2,118.00 | 2,118.00 | 2,052.00 | 2,052.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Security Brokers & Dealers | 921.7M | 473.4M | 1.6289 | 13.04 | 6.02B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:39:19 | AT | 1,398 | 2,120.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 18/7/2024 | 07:00 | UKREG | Intermediate Capital Group plc: Block Listing Six Monthly |
| 16/7/2024 | 11:50 | UKREG | Intermediate Capital Group plc: Results of 2024 Annual General Meeting |
| 16/7/2024 | 10:49 | ALNC |  IN BRIEF: Intermediate Capital assets under management rise |
| 16/7/2024 | 07:00 | UKREG | Intermediate Capital Group plc: Q1 Trading Statement for the three months.. |
| 12/6/2024 | 17:30 | UKREG | Intermediate Capital Group plc: Annual Report and Accounts |
| 07/6/2024 | 15:15 | UKREG | Intermediate Capital Group plc: Notification of Transactions of Directors |
| 07/6/2024 | 15:10 | UKREG | Intermediate Capital Group plc: Vesting in Share Awards/ Notification of.. |
| 04/6/2024 | 09:18 | UKREG | ICG : Director Declaration |
| 28/5/2024 | 09:46 | ALNC | TOP NEWS: Intermediate Capital ups dividend as profit surges |
| 28/5/2024 | 07:00 | UKREG | ICG: Final Results for the financial year ended 31 March 2024 |
Intermediate Capital (ICG) Share Charts1 Year Intermediate Capital Chart |
|
1 Month Intermediate Capital Chart |
Intraday Intermediate Capital Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 25/7/2024 | 11:52 | Intermediate Capital - a conservative lender with upside - cont'd | 35 |
| 16/7/2024 | 15:51 | Intermediate Capital Group | 27 |
| 28/9/2000 | 14:48 | Intermediate Capital Group (ICG) looks very promising..... | - |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 15:39:19 | 2,120.00 | 1,398 | 29,637.60 | AT |
| 2024-07-26 15:39:19 | 2,120.00 | 683 | 14,479.60 | AT |
| 2024-07-26 15:38:58 | 2,120.00 | 275 | 5,830.00 | AT |
| 2024-07-26 15:38:58 | 2,120.00 | 600 | 12,720.00 | AT |
| 2024-07-26 15:38:58 | 2,120.00 | 4,473 | 94,827.60 | AT |
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Intermediate Capital Daily Update Intermediate Capital Group Plc is listed in the Security Brokers & Dealers sector of the London Stock Exchange with ticker ICG. The last closing price for Intermediate Capital was 2,070p.Intermediate Capital currently has 290,631,993 shares in issue. The market capitalisation of Intermediate Capital is £6,173,023,531. Intermediate Capital has a price to earnings ratio (PE ratio) of 13.04. This morning ICG shares opened at 2,052p |
Posted at 17/7/2024 09:24 by its the oxman Guess temporary share price weakness might be due to fee earning funds being below consensus. But an opportunity as the finds are there to deploy so more a timing issue than anything else. Intermediate Capital Group raised more funds than expected at the start of its fiscal year amid "elevated" transaction activity.During the quarter ending in June, assets under management at the alternative asset manager rose by 23.7% year-on-year to reach $101bn (consensus: $97.82bn).But of that amount only $70bn were fee-earning (consensus: $71.69bn) following 10% growth in annual terms.The firm raised $4.7bn of new funds during the quarter (consensus: $3.44bn), including $2.1bn for its Senior Debt fund and another $1.4bn for the Strategic Equity V fund.Analysts at UBS had anticipated $0.5bn in monies raised for each of those funds.Intermediate Capital deployed $3.9bn of funds during the period and achieved realisations of $2.5bn, against $1.0bn and $0.6bn one year before, respectively.The firm's expectations were unchanged from at the time of its full-year results presentation.As of 1242 BST, shares in Intermediate Capital were slipping by 1.34% to 2,208.0p. |
Posted at 16/7/2024 15:51 by martinmc123 Intermediate Capital Group issued an upbeat Q1 update which confirmed that AUM reached $101b at 30th June 2024. This was up 3% over the previous quarter and 23.7% yoy, leaving the 5-year CAGR at 19.5%. This is pretty impressive AUM growth over both the past 1- and 5-years and should continue to feed through into more robust topline and bottom-line growth. Valuation is average for the IB&IS sector with forward PE ratio at 13.0x, but it is relatively cheap given the share’s own recent trading performance – the trailing 12-month PE ratio has traded over 15x in 5 of the past 6 years. There is both a solid EPS growth outlook and some upward rerating potential here. Last but not least, the share price has solid positive momentum and is currently testing resistance around record highs. A move through the 2400p level opens up uncharted territory and with monetary policy easing cycles set to start on both sides of the Atlantic though H2, asset prices could extend their good run for a while from here on. BUY......from WealthOracle wealthoracle.co.uk/d |
Posted at 05/6/2024 16:54 by pvb Funding development in today’s market3 June 2024 Development viability has changed, but that may be good news for debt investors, says ICG Real Estate’s Jai Patel |
Posted at 28/5/2024 08:06 by its the oxman Strong results eps, fum, etc Div increase only slight disappointment. That said targets outlined to raise 55bn over next 4 years shows how much growth is to come and should justify a continued increase in the share price. Morning presentation to come as well. |
Posted at 27/5/2024 18:55 by dustinthyme hxxps://theoakbloke. |
Posted at 23/5/2024 12:30 by zeppo More from this amazing company!Grey Wolf Therapeutics closes oversubscribed $50 million Series B financing expansion, led by ICG Life Sciences team, to accelerate and expand first-of-its-kind antigen modulation technology Brings total Series B funds raised to nearly $100 million Proceeds to support broadening scope of ongoing clinical trial of GRWD5769; first clinical data to be reported at ASCO 2024 Company to expand R&D efforts to develop disease-modifying therapies for autoimmune disorders Grey Wolf Therapeutics, a clinical-stage biotechnology company leveraging first-of-its-kind antigen modulation therapies to address the source of immune dysfunction in oncology and autoimmunity, today announced the closing of an oversubscribed $50 million Series B financing expansion, bringing the total amount of Series B funds raised to $99 million. The Series B expansion round was led by ICG’s Life Sciences team and included further investment from existing investors Pfizer Ventures, Andera Partners, Canaan, Earlybird Venture Capital, Oxford Science Enterprises and British Patient Capital. Proceeds from the round will be leveraged to broaden the scope of the company’s ongoing Phase 1/2 clinical trial of its lead immuno-oncology candidate, GRWD5769, in a range of solid tumour types. The funding also enables the company to expand research and development (R&D) for its versatile antigen modulation approach into treatments for autoimmune disease indications. Tracy Weightman, Associate Director at ICG, said: "Grey Wolf is an exciting growth stage UK biotechnology company with a novel and differentiated approach that has the potential to transform the lives of millions of patients globally. This investment demonstrates our commitment to building leading biotechnology companies and enabling them to compete on a global stage. We are pleased to support Grey Wolf through the next stage of its growth journey, enabling the company to advance its clinical development strategy and expand into new therapeutic areas." |
Posted at 22/5/2024 19:57 by zeppo hxxps://www.icgam.coICG and Teras launch Templus, the first Southern Europe regional data ... Today Templus utilises a new business model premised on infrastructure's close-to-end customers, digital security, and the highest standards of sustainability and energy efficiency. ICG, the global alternative asset manager, and Teras Capital (" Teras "), the investment platform led by successful digital This and Full Year Results on 28th May: Wow! |
Posted at 06/5/2024 19:35 by its the oxman Based on 6 Wall Street analysts offering 12 month price targets for Intermediate Capital in the last 3 months. The average price target is 2,370.00p with a high forecast of 2,600.00p and a low forecast of 2,250.00p. The average price target represents a 10.13% change from the last price of 2,152.00p.Let's go for the high forecast. ? |
Posted at 19/4/2024 13:29 by pvb Rocky markets, rocky share price! Now we are back under £20. |
Posted at 15/4/2024 10:09 by its the oxman !FOLLOWFEEDNew ticker , new thread cont'd for ICG ,a global alternative asset manager with a 35-year track record. We are driven by purpose and sustainable results. We deliver outstanding investment performance to our clients, provide wide‐ranging capital solutions for corporates and owners of real assets, and create value for stakeholders, shareholders and communities. Assets managed over four classes, Structured and Private Equity, Private Debt, Real Assets and Credit. Been one of my longer term holdings with ups and downs over the years but longer term shown a real ability to grow AUM strongly often regardless of market conditions. As it becomes a bigger more profitable business the div and share price should have scope to increase significantly. All contributions and insights very welcome. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
